SOURCE: MedeFile International, Inc.

MedeFile International, Inc.

May 09, 2011 08:30 ET

MedeFile International Engages HealthPro BioVentures to Pursue Strategic Marketing Partnerships in Healthcare Industry

BOCA RATON, FL--(Marketwire - May 9, 2011) - MedeFile International, Inc. (OTCQB: MDFI) (PINKSHEETS: MDFI), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced that it has engaged HealthPro BioVentures, LLC with the sole objective of pursuing and structuring strategic co-marketing partnerships and healthcare IT collaborations with companies operating within the global healthcare arena.

John Andreadis, Managing Partner at HealthPro BioVentures, stated, "For the past several years, we have been closely monitoring MedeFile's progress in the emerging Personal Health Record management space and have been duly impressed with the systematic and elegant evolution of the Company's iPHR platform. In our professional opinion, the rich and intuitive functionality and robust feature set of the MedeFile system makes it the superior PHR solution on the market today, which bodes extremely well for the future of MedeFile. Consequently, HealthPro BioVentures looks forward to working in concert with MedeFile's management team to leverage our longstanding relationships with major companies in the healthcare industry to pursue opportunities that will help promote mass adoption of the MedeFile platform as the preferred personal health record management solution."

"We are very pleased to formalize our relationship with HealthPro BioVentures," noted Kevin Hauser, Chairman, CEO and President of MedeFile. "John and his team have already proven to be instrumental in helping to strengthen our Company's growth platform through their introduction of Dr. Gurinder Shahi, who now serves on our corporate advisory board. Recognizing that HealthPro BioVentures enjoys a highly respected reputation among the world's largest healthcare and life sciences companies, we have tremendous confidence in their ability to assist us in securing meaningful strategic partnerships with groups that will fuel MedeFile membership growth and help us to ultimately achieve noted market dominance."

About HealthPro BioVentures, LLC
HealthPro BioVentures is a life sciences investment bank and strategic advisory firm serving the Biotechnology, Biomedical, Healthcare, and Pharmaceutical sectors. HealthPro BioVentures' network of contacts includes first-tier healthcare venture capital firms, senior level executives at hundreds of public and private biotech companies, specialty pharma companies and major research institutions.

For more information, visit our website at www.healthprobioventures.com.

About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records. Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com. You can also follow the Company on Twitter and Facebook.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

Contact Information

  • FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
    Elite Financial Communications Group, LLC
    Dodi B. Handy
    President and CEO
    (Twitter: dodihandy)
    For Media:
    Kathy Addison
    COO
    (Twitter: kathyaddison)
    (407) 585-1080
    via email at Email Contact